Arthritic Therapeutic Market Poised for 6.1% Growth, Set to Hit $91.7 Billion by 2029

Which drivers are expected to have the greatest impact on the over the arthritic therapeutic market's growth?
The increasing prevalence of arthritis is expected to accelerate the growth of the arthritic therapeutic market. Arthritis encompasses over 100 conditions, mainly involving joint pain and inflammation. The rising incidence of arthritis is attributed to an aging population, higher obesity rates, and lifestyle factors contributing to joint stress. Treatments for arthritis aim to alleviate symptoms, reduce inflammation, and improve joint function, enhancing the overall quality of life for patients. For instance, in June 2024, the Australian Institute of Health and Welfare reported that around 514,000 people in Australia were living with rheumatoid arthritis in 2022, representing 2.0% of the population. This rise in arthritis cases is fueling the growth of the arthritic therapeutic market.

Get Your Arthritic Therapeutic Market Report Here:
https://www.thebusinessresearchcompany.com/report/arthritic-therapeutic-global-market-report

What is the future CAGR of the arthritic therapeutic market, and how will it impact industry expansion?
The arthritic therapeutic market has shown strong growth in recent years. It is expected to rise from $68.1 billion in 2024 to $72.44 billion in 2025, with a CAGR of 6.4%. This growth in the past can be credited to an increasing number of diagnosed patients, greater awareness of symptoms, a higher prevalence of obesity, improved diagnostic capabilities, and advancements in treatment outcomes.

The arthritic therapeutic market is anticipated to witness robust growth over the next few years, reaching $91.72 billion by 2029 at a CAGR of 6.1%. This growth can be attributed to enhanced healthcare infrastructure, supportive government initiatives, favorable regulatory policies, a growing focus on personalized medicine, and a shift toward patient-centric healthcare models. Major trends expected in the forecast period include an increased focus on biosimilars, a transition toward biologics, greater availability of biosimilars, a preference for parenteral administration, and the expansion of online pharmacies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19297&type=smp

What are the most significant trends transforming the arthritic therapeutic market today?
In the arthritis therapeutic market, companies are focusing on biosimilar monoclonal antibody-based therapies to enhance treatment efficacy and reduce costs. A notable example is Bio-Thera Solutions Ltd., which launched TOFIDENCE, a biosimilar monoclonal antibody for treating rheumatoid arthritis and related conditions. This development allows patients to access more affordable treatments that replicate the therapeutic benefits of the original monoclonal antibody, ACTEMRA, offering a lower-cost alternative with similar effectiveness.

Which key market segments comprise the arthritic therapeutic market and drive its revenue growth?
The arthritic therapeuticmarket covered in this report is segmented -

1) By Drug Class: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Xanthine Oxidase Inhibitors, Other Drug Classes
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Type: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, Gout, Other Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab, Etanercept, Infliximab, Certolizumab Pegol, Golimumab
2) By Interleukin Inhibitors: Interleukin-6 (IL-6) Inhibitors, Interleukin-1 (IL-1) Inhibitors, Interleukin-17 (IL-17) Inhibitors, Interleukin-23 (IL-23) Inhibitors
3) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Meloxicam
4) By Corticosteroids: Prednisone, Methylprednisolone, Hydrocortisone, Dexamethasone
5) By Xanthine Oxidase Inhibitors: Allopurinol, Febuxostat
6) By Other Drug Classes: Disease-Modifying Antirheumatic Drugs (DMARDs), Janus Kinase (JAK) Inhibitors, Biologic DMARDs, Topical Analgesics, Opioid Pain Medications

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19297

What regions are at the forefront of arthritic therapeutic market expansion?
North America was the largest region in the arthritic therapeutic market in 2024. The regions covered in the arthritic therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the arthritic therapeutic market?
Major companies operating in the arthritic therapeutic market are Pfizer Inc., Johnson & Johnson, Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Pharma AB, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., UCB Pharma S.A., Incyte Corporation, Celltrion Inc., Mallinckrodt Pharmaceuticals, Genentech Inc., Anika Therapeutics Inc., Medac GmbH

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=19297&type=smp

What Is Covered In The Arthritic Therapeutic Global Market Report?

•Market Size Forecast: Examine the arthritic therapeutic market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the arthritic therapeutic market for a structured understanding.
•Key Players Overview: Analyze major players in the arthritic therapeutic market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the arthritic therapeutic market.
•Segment Contributions: Evaluate how different segments drive overall growth in the arthritic therapeutic market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the arthritic therapeutic market.
•Industry Challenges: Identify potential risks and obstacles affecting the arthritic therapeutic market.
•Competitive Landscape: Review strategic developments in the arthritic therapeutic market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.